Oncternal Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.08
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.24
|
-0.21
|
0.03
|
12.50%
|
|
2022-06-30
|
-0.23
|
-0.23
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.20
|
-0.20
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.25
|
-0.16
|
0.09
|
36.00%
|
|
2021-09-30
|
-0.16
|
-0.19
|
-0.03
|
-18.75%
|
|
2021-06-30
|
-0.14
|
-0.16
|
-0.02
|
-14.29%
|
|
2021-03-31
|
-0.10
|
-0.12
|
-0.02
|
-20.00%
|
|
2020-12-31
|
-0.18
|
-0.09
|
0.09
|
50.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.64
|
|
2021-12-31
|
-0.63
|
|
2020-12-31
|
-0.96
|
|
2019-12-31
|
-4.21
|
|
2018-12-31
|
-1.66
|
|
2017-12-31
|
-4.15
|
|
2016-12-31
|
-1.24
|
|
2015-12-31
|
-4.40
|
|
2014-12-31
|
-3.46
|
|
2013-12-31
|
-6.60
|
|
2012-12-31
|
-6.00
|
|
2011-12-31
|
-5.80
|
|
2010-12-31
|
4.60
|
|
2009-12-31
|
-12.70
|
|
2008-12-31
|
-14.30
|
|
2007-12-31
|
-11.40
|
|
2006-12-31
|
-11.40
|
|
2005-12-31
|
-14.40
|
|
2004-12-31
|
-9.30
|
|
2003-12-31
|
-140.96
|